The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

rubicor.com

Founded Year

1998

Stage

Series C | Alive

Total Raised

$30M

Last Raised

$30M | 16 yrs ago

About Rubicor Medical

Rubicor Medical is a private medical device company located in Redwood City, California. Our proprietary biopsy technology (Ovation Breast Biopsy Device) is a dramatic improvement over current minimally invasive biopsy technologies. The Ovation system is comprised of a 14-gauge biopsy device capable of excising, capturing and extracting an intact 2.5 cm diameter tissue sample. Ovation is compatible with either ultrasound or stereotactic image guidance. Rubicor was co-founded by Dr. James Vetter and has been privately funded by a consortium of individual investors.James W. Vetter, M.D., CEO and Chairman of the Board, is a board certified interventional cardiologist.He is an Associate Professor of Clinical Medicine at Stanford University Hospital, where he iscurrently on Active Staff status as community faculty. Dr. Vetter is a graduate of the MedicalCollege of Wisconsin where he completed a residency in internal medicine and a fellowship incardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. John SimpsonM.D./PhD., at Sequoia Hospital, Redwood City, California. Dr. Vetter is a member of the Alpha OmegaAlpha Honor Society and the American College of Cardiologists. He has published six articles andseveral book chapters as well as over 35 abstracts. Dr. Vetter has held positions as a member of thePhysician Advisory Council and/or board member with a number of medical device companiesincluding Guidant, Lumend, Fox Hollow and CardioVasc. He is also a board member of MagellanSystems International, Inc.Dr. Vetter has extensive experience in working with new medical device concepts and designs,working with R&D engineers to develop working prototypes and clinically testing and refining thoseproducts. He was co-founder of Perclose and was involved with that company from inception toinitial public offering and eventual sale to Abbott Labs. He is a "hands on" clinician with access toresources and expertise needed to build a successful medical device and company. Dr. Vetter hashad a number of patents issued in his name as co-inventor.Ary Chernomorsky, V.P. of R&D since 2000 has over 23 years experience in the medical deviceindustry. Prior to joining Rubicor, Mr. Chernomorsky was employed by the Vascular Therapiesdivision of US Surgical Company (acquired by Tyco International), where he served as a Director ofR&D. Mr. Chernomorsky has been involved with various startup companies in the R&D Director andManager capacities including: PAS Inc. (acquired by USS), Advanced Surgical, Inc. (acquired byImagyn), Micro Therapeutics, Bausch and Lomb, Mentor Corporation and Dart Industries Inc. Aryholds an M.S. in Polymer Engineering from LIT and an M.S. in Biomedical Engineering from RutgersUniversity.Tony Difede, CPA, V.P. Finance holds a BSBA degree in Accounting from the University of Floridaand a M.S. in Taxation from Pace University. He has held management positions in tax and accountingwith Ernst & Young, KPMG and my CFO, Inc. His clients have included closely held start-upcompanies as well as large multinational public corporations. He is licensed in California and NewJersey. He has extensive experience in accounting for stock options and issues regarding closelyheld companies and their high net worth owners and investors.COMPANY INFOMANAGEMENTpage 12006 Company Overview (Continued)Breast care. Completely redefined.James W. Vetter, M.D., Founder and Chairman of the Board, is a board certified interventionalcardiologist. He is an Associate Professor of Clinical Medicine at Stanford University Hospital,where he is currently on Active Staff status as community faculty. Dr. Vetter is a graduate of theMedical College of Wisconsin where he completed a residency in internal medicine and a fellowshipin cardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. JohnSimpson M.D./PhD., at Sequoia Hospital, Redwood City, Cal

Rubicor Medical Headquarter Location

600 Chesapeake Drive

Redwood City, California, 94063,

United States

650-587-3447

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Rubicor Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Rubicor Medical is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Rubicor Medical Patents

Rubicor Medical has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/30/2009

5/1/2012

Investment funds, Spinning, Dermal and subcutaneous growths

Grant

Application Date

12/30/2009

Grant Date

5/1/2012

Title

Related Topics

Investment funds, Spinning, Dermal and subcutaneous growths

Status

Grant

  • When was Rubicor Medical founded?

    Rubicor Medical was founded in 1998.

  • Where is Rubicor Medical's headquarters?

    Rubicor Medical's headquarters is located at 600 Chesapeake Drive, Redwood City.

  • What is Rubicor Medical's latest funding round?

    Rubicor Medical's latest funding round is Series C.

  • How much did Rubicor Medical raise?

    Rubicor Medical raised a total of $30M.

  • Who are the investors of Rubicor Medical?

    Investors of Rubicor Medical include ITX International and Safeguard Scientifics.

  • Who are Rubicor Medical's competitors?

    Competitors of Rubicor Medical include JJET, Linkage Biosciences, Aviir, Predictive Biosciences, VitaPath Genetics and 9 more.

You May Also Like

J
JJET

JJET is committed to the development, production, and sales of products in the field of electrophysiology, the products mainly include a three-dimensional cardiac mapping system, multi-channel physiological recorder, cardiac electrophysiological stimulator, cardiac radiofrequency ablation device, cold saline perfusion pump, cardiac electrophysiological mapping catheter, cardiac radiofrequency ablation catheter, nerve radiofrequency treatment instrument.

F
Flex Biomedical

Flex Biomedical is developing technologies to treat and diagnose orthopedic diseases. Flex Biomedical's lead product is a synthetic polymer, the Flex Polymer, designed to treat osteoarthritis.

X
Xeptagen S.p.A.

XEPTAGEN SpA is engaged in the discovery and validation of molecular markers in order to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. By exploiting the natural immune response to early stage cancer and the platform technology Combinatorial Proteomic, XEPTAGEN has discovered specific tumor markers that lead to an earlier and much more accurate detection of developing carcinomas. The company's mission includes creating tools that improve the diagnostic accuracy for cancer and the clinical management of cancer patients.

L
Litholink

Litholink offers metabolic evaluations for kidney stone formers.

T
Thermal Energy

TECO provides district heating and cooling service to buildings on the Texas Medical Center campus in Houston, Texas. The company operates two heating and cooling plants with a combined capacity of 80,000 tons of chilled water and 762,000 lbs/hr of steam production.

C
Columbia BioSystems

Columbia BioSystems Inc. is a company engaged in molecular Nano-diagnostics using Molecularly Imprinted Polymers (MIPs) for the rapid detection of pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA) , Anthrax, HIV, and Trypanosomiasis (sleeping sickness). The company uses MIPs to bind to proteins and, upon binding, change color thereby signaling the presence of the bacteria, virus or parasite.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.